{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:30:46Z","timestamp":1783463446762,"version":"3.55.0"},"reference-count":228,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31500807"],"award-info":[{"award-number":["31500807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jconrel.2021.11.040","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T12:51:17Z","timestamp":1638190277000},"page":"364-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Bridging micro\/nano-platform and airway allergy intervention"],"prefix":"10.1016","volume":"341","author":[{"given":"Meng-jie","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-sheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.prrv.2003.09.010","article-title":"Therapeutic strategies for allergic airways diseases","volume":"5","author":"Carlsen","year":"2004","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0010","first-page":"69","article-title":"A bug's view of allergic airways disease","volume":"19","author":"Hsu","year":"2016","journal-title":"Paediatr. Respir. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2021.11.040_bb0015","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.bbagen.2011.04.019","article-title":"Proteinases as molecular adjuvants in allergic airway disease","volume":"1810","author":"Porter","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"22","key":"10.1016\/j.jconrel.2021.11.040_bb0020","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1021\/jm501102h","article-title":"The discovery of potent, selective, and reversible inhibitors of the house dust mite peptidase allergen Der p 1: an innovative approach to the treatment of allergic asthma","volume":"57","author":"Newton","year":"2014","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.jconrel.2021.11.040_bb0025","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1021\/acs.est.6b04908","article-title":"Air pollution and climate change effects on allergies in the anthropocene: abundance, interaction, and modification of allergens and adjuvants","volume":"51","author":"Reinmuth-Selzle","year":"2017","journal-title":"Environ. Sci. Technol."},{"issue":"6 Suppl 2","key":"10.1016\/j.jconrel.2021.11.040_bb0030","first-page":"S7","article-title":"Improved strategies and new treatment options for allergic rhinitis","volume":"102","author":"Willsie","year":"2002","journal-title":"J Am Osteopath Assoc"},{"issue":"9","key":"10.1016\/j.jconrel.2021.11.040_bb0035","first-page":"30","article-title":"Allergic rhinitis: guide to diagnosis, allergen avoidance and treatment","volume":"23","author":"Farooque","year":"2012"},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2021.11.040_bb0040","first-page":"S35","article-title":"Pharmacotherapy for allergic rhinitis","volume":"4","author":"Platt","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"issue":"10","key":"10.1016\/j.jconrel.2021.11.040_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/acsami.7b14992","article-title":"Mucus and cell-penetrating nanoparticles embedded in nano-into-micro formulations for pulmonary delivery of Ivacaftor in patients","volume":"10","author":"Porsio","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.jconrel.2021.11.040_bb0050","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1021\/am400762q","article-title":"Quasi-immiscible spreading of aqueous surfactant solutions on entangled aqueous polymer solution subphases","volume":"5","author":"Sharma","year":"2013","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.jconrel.2021.11.040_bb0055","doi-asserted-by":"crossref","first-page":"1803776","DOI":"10.1002\/smll.201803776","article-title":"Bismuth ferrite second harmonic nanoparticles for pulmonary macrophagetracking","volume":"15","author":"Ramos-Gomes","year":"2019","journal-title":"Small"},{"issue":"11","key":"10.1016\/j.jconrel.2021.11.040_bb0060","doi-asserted-by":"crossref","first-page":"2000164","DOI":"10.1002\/adhm.202000164","article-title":"Nano and microparticle emerging strategies for treatment of autoimmune diseases: multiple sclerosis and type 1 diabetes","volume":"9","author":"Kwiatkowski","year":"2020","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0065","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/1744666X.2017.1333423","article-title":"Allergen immunotherapy in allergic rhinitis: Current use and future trends","volume":"13","author":"Klimek","year":"2017","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13601-018-0210-2","article-title":"Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management","volume":"8","author":"Bachert","year":"2018","journal-title":"Clin. Translat. Allergy"},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.prrv.2009.02.002","article-title":"Allergic rhinitis","volume":"10","author":"Kemp","year":"2009","journal-title":"Paediatr. Respir. Rev."},{"issue":"86","key":"10.1016\/j.jconrel.2021.11.040_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2) LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ACI.0b013e32833653d7","article-title":"Gene-environment interactions in asthma and allergy: the end of the beginning?","volume":"10","author":"Vercelli","year":"2010","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"9809","key":"10.1016\/j.jconrel.2021.11.040_bb0090","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(11)60130-X","article-title":"Allergic rhinitis","volume":"378","author":"Greiner","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00130832-200102000-00010","article-title":"Allergen uptake and presentation by dendritic cells","volume":"1","author":"Lambrecht","year":"2001","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2021.11.040_bb0100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cell.2010.03.004","article-title":"Asthma and allergic inflammation","volume":"140","author":"Locksley","year":"2010","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.jconrel.2021.11.040_bb0105","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.4049\/jimmunol.174.8.5024","article-title":"Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis","volume":"174","author":"Takhar","year":"2005","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2021.11.040_bb0110","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4168\/aair.2010.2.2.65","article-title":"The pathophysiology, diagnosis and treatment of allergic rhinitis","volume":"2","author":"Yang-Gi","year":"2010","journal-title":"Allergy, Asthma Immunol. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2021.11.040_bb0120","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/07853890701449354","article-title":"Triggers of IgE class switching and allergy development","volume":"39","author":"Poulsen","year":"2007","journal-title":"Ann. Med."},{"issue":"11","key":"10.1016\/j.jconrel.2021.11.040_bb0125","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/01.SMJ.0000097887.04639.39","article-title":"Molecular mechanisms of allergic disease","volume":"96","author":"Venarske","year":"2003","journal-title":"South. Med. J."},{"issue":"11","key":"10.1016\/j.jconrel.2021.11.040_bb0130","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.intimp.2011.07.005","article-title":"Allergic rhinitis: an update on disease, present treatments and future prospects","volume":"11","author":"Mandhane","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrd2153","article-title":"Inhaling medicines: delivering drugs to the body through the lungs","volume":"6","author":"Patton","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S2213-2600(13)70072-9","article-title":"Pulmonary drug delivery: from generating aerosols to overcoming bio logical barriers \u2013 therapeutic possibilities and technological challenges","volume":"1","author":"Ruge","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"6 Pt 2","key":"10.1016\/j.jconrel.2021.11.040_bb0145","doi-asserted-by":"crossref","first-page":"S610","DOI":"10.1067\/mai.2000.106151","article-title":"Allergic rhinitis: treating the adult","volume":"105","author":"Corren","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13223-018-0314-1","article-title":"The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option","volume":"15","author":"Bjermer","year":"2019","journal-title":"Allergy, Asthma Clin. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2021.11.040_bb0155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1396-0296.2004.04036.x","article-title":"Corticosteroids","volume":"17","author":"Isaksson","year":"2004","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1517\/13543780903435647","article-title":"Investigational drugs for allergic rhinitis","volume":"19","author":"Passalacqua","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"3","key":"10.1016\/j.jconrel.2021.11.040_bb0165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaci.2004.11.053","article-title":"The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation","volume":"115","author":"Holgate","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2021.11.040_bb0170","first-page":"355","article-title":"Novel treatments of asthma and allergic diseases","volume":"15","author":"Chini","year":"2014","journal-title":"Paediatr. Respir. Rev."},{"issue":"S24","key":"10.1016\/j.jconrel.2021.11.040_bb0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/pai.13161","article-title":"Allergen immunotherapy and asthma","volume":"31","author":"Tosca","year":"2020","journal-title":"Pediatr. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0180","first-page":"29","article-title":"Specific immunotherapy by the sublingual route for respiratory allergy","volume":"6","author":"Incorvaia","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"Suppl. 108","key":"10.1016\/j.jconrel.2021.11.040_bb0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/all.14077","article-title":"Perspectives in allergen immunotherapy: 2019 and beyond","volume":"74","author":"Pfaar","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0190","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1039\/D0TB02590A","article-title":"Nanosystems as curative platforms for allergic disorder management","volume":"9","author":"Fan","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118813","article-title":"Nasal route for vaccine and drug delivery: features and current opportunities","volume":"572","author":"Lobaina Mato","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"35","key":"10.1016\/j.jconrel.2021.11.040_bb0200","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.2174\/0929867326666190827151741","article-title":"Intranasal nanoparticulate systems as alternative route of drug delivery","volume":"26","author":"Areen","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119166","article-title":"Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation","volume":"579","author":"Alshweiat","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2021.11.040_bb0210","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s12272-016-0782-0","article-title":"Hydrogel nanoparticles and nanocomposites for nasal drug\/vaccine delivery","volume":"39","author":"Salatin","year":"2016","journal-title":"Arch. Pharm. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2021.11.040_bb0215","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.chest.2019.11.036","article-title":"Intratracheal delivery of nano- and microparticles and hyperpolarized gases: a promising strategy for the imaging and treatment of respiratory disease","volume":"157","author":"Wang","year":"2020","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.jconrel.2021.11.040_bb0220","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1007\/s12274-016-1108-8","article-title":"Pulmonary administration of functionalized nanoparticles significantly reduces beta-amyloid in the brain of an Alzheimer\u2019s disease murine model","volume":"9","author":"Sancini","year":"2016","journal-title":"Nano Res."},{"issue":"6","key":"10.1016\/j.jconrel.2021.11.040_bb0225","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.actbio.2014.01.033","article-title":"Polymeric nanoparticles for pulmonary protein and DNA delivery","volume":"10","author":"Menon","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2018.05.031","article-title":"Sustained therapeutic efficacy of budesonide-loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and dose","volume":"283","author":"Zhang","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0235","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.actbio.2019.06.056","article-title":"In vitro-in vivo correlation of inhalable budesonide-loaded large porous particles for sustained treatment regimen of asthma","volume":"96","author":"Li","year":"2019","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0142-9612(03)00477-0","article-title":"Preparation and characterization of starch\/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy\u00ae) in allergic rhinitis treatment","volume":"25","author":"Fundueanu","year":"2004","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0245","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ijpharm.2015.09.052","article-title":"Interest of cyclodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide","volume":"495","author":"Dufour","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"22","key":"10.1016\/j.jconrel.2021.11.040_bb0250","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.7150\/thno.28324","article-title":"Therapeutic fluorescent hybrid nanoparticles for traceable delivery of glucocorticoids to inflammatory sites","volume":"8","author":"Napp","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0255","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jconrel.2016.04.039","article-title":"Porous antioxidant polymer microparticles as therapeutic systems for the airway inflammatory diseases","volume":"233","author":"Jeong","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0260","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ejphar.2016.10.014","article-title":"Conjugated Alpha-Alumina nanoparticle with vasoactive intestinal peptide as a nano-drug in treatment of allergic asthma in mice","volume":"791","author":"Athari","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0265","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2014.02.010","article-title":"DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma","volume":"180","author":"da Silva","year":"2014","journal-title":"J. Control. Release"},{"issue":"22","key":"10.1016\/j.jconrel.2021.11.040_bb0270","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1016\/j.biomaterials.2007.03.029","article-title":"Water-soluble chitosan-based antisense oligodeoxynucleotide of interleukin-5 for treatment of allergic rhinitis","volume":"28","author":"Kim","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119034","article-title":"CD13-specific ligand facilitates Xanthatin nanomedicine targeting dendritic cells for therapy of refractory allergic rhinitis","volume":"577","author":"Zheng","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0280","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.drudis.2014.09.020","article-title":"Recent advances in controlled pulmonary drug delivery","volume":"20","author":"Liang","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0285","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.ijbiomac.2019.05.188","article-title":"Nasal adaptive chitosan-based nano-vehicles for anti-allergic drug delivery","volume":"135","author":"Sun","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0290","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1773-2247(10)50004-2","article-title":"The potential of chitosan for pulmonary drug delivery","volume":"20","author":"Grenha","year":"2010","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0295","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.colsurfb.2011.01.030","article-title":"Chitosan microspheres as a delivery system for nasal insufflation","volume":"84","author":"Patil","year":"2011","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"4","key":"10.1016\/j.jconrel.2021.11.040_bb0300","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1021\/acs.biomac.0c00071","article-title":"Hydroxybutyl chitosan centered biocomposites for potential curative applications: a critical review","volume":"21","author":"Sun","year":"2020","journal-title":"Biomacromolecules"},{"issue":"1-3","key":"10.1016\/j.jconrel.2021.11.040_bb0305","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2004.07.030","article-title":"Transmucosal macromolecular drug delivery","volume":"101","author":"Prego","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0310","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/17425247.4.3.297","article-title":"Design of fine particles for pulmonary drug delivery","volume":"4","author":"Weers","year":"2007","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0315","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jconrel.2004.10.010","article-title":"Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions","volume":"102","author":"Yamamoto","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0320","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jconrel.2021.05.048","article-title":"Chitosan-centered nanosystems as sustained therapeutics for allergic rhinitis intervention: Inhibition of histamine-induced cascades","volume":"335","author":"Sun","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0325","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.colsurfb.2017.07.038","article-title":"Recent applications of PLGA based nanostructures in drug delivery","volume":"159","author":"Mir","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"3","key":"10.1016\/j.jconrel.2021.11.040_bb0330","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1098\/rsfs.2011.0123","article-title":"Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine","volume":"2","author":"Pan","year":"2012","journal-title":"Interface Focus"},{"issue":"6","key":"10.1016\/j.jconrel.2021.11.040_bb0335","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cossms.2013.01.001","article-title":"Polymeric nanomedicines based on poly(lactide) and poly(lactide-co-glycolide)","volume":"16","author":"Tong","year":"2012","journal-title":"Curr. Opin. Solid State Mater. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2021.11.040_bb0340","doi-asserted-by":"crossref","first-page":"516","DOI":"10.4314\/tjpr.v13i7.24","article-title":"Biodegradable poly(D,L-lactic-co-glycolic acid)-based micro\/nanoparticles for sustained release of protein drugs - a review","volume":"13","author":"Ansary","year":"2014","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/794601","article-title":"Recent trends in preparation of poly(lactide-co-glycolide) nanoparticles by mixing polymeric organic solution with antisolvent","volume":"2015","author":"Sah","year":"2015","journal-title":"J. Nanomater."},{"issue":"1-2","key":"10.1016\/j.jconrel.2021.11.040_bb0350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10847-008-9456-y","article-title":"Cyclodextrin based novel drug delivery systems","volume":"62","author":"Vyas","year":"2008","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"issue":"4","key":"10.1016\/j.jconrel.2021.11.040_bb0355","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1039\/b705458k","article-title":"Cyclodextrin-based supramolecular polymers","volume":"38","author":"Harada","year":"2009","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0360","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1039\/B816354P","article-title":"Cyclodextrin-based bioactive supramolecular assemblies","volume":"39","author":"Chen","year":"2010","journal-title":"Chem. Soc. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2021.11.040_bb0365","article-title":"Biodegradable polyoxalate and copolyoxalate particles for drug-delivery applications","volume":"2","author":"Hong","year":"2011","journal-title":"Therapeutic Dilivery"},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0370","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2012.10.015","article-title":"Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a review","volume":"165","author":"Ford Versypt","year":"2013","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2021.11.040_bb0375","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/jbm.b.33648","article-title":"Polymer degradation and drug delivery in PLGA-based drug-polymer applications: a review of experiments and theories","volume":"105","author":"Xu","year":"2017","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"8","key":"10.1016\/j.jconrel.2021.11.040_bb0380","doi-asserted-by":"crossref","first-page":"71550","DOI":"10.1371\/journal.pone.0071550","article-title":"The multifunctional Ca2+\/calmodulin-dependent kinase II delta (CaMKII delta) regulates arteriogenesis in a mouse model of flow-mediated remodeling","volume":"8","author":"Scott","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0385","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.vph.2014.01.001","article-title":"Oxidative activation of the Ca2+\/calmodulin-dependent protein kinase II (CaMKII) regulates vascular smooth muscle migration and apoptosis","volume":"60","author":"Zhu","year":"2014","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0390","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yjmcc.2015.10.014","article-title":"Oxidant stress promotes disease by activating CaMKII","volume":"89","author":"Anderson","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"195","key":"10.1016\/j.jconrel.2021.11.040_bb0395","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1126\/scitranslmed.3006135","article-title":"CaMKII is essential for the proasthmatic effects of oxidation","volume":"5","author":"Sanders","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2021.11.040_bb0400","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1021\/acs.molpharmaceut.7b00114","article-title":"Cationic CaMKII inhibiting nanoparticles prevent allergic asthma","volume":"14","author":"Morris","year":"2017","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.jconrel.2021.11.040_bb0405","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1039\/C8BM00466H","article-title":"Immunomodulatory vasoactive intestinal peptide amphiphile micelles","volume":"6","author":"Zhang","year":"2018","journal-title":"Biomater Sci"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0410","first-page":"500","article-title":"Vasoactive intestinal peptide (VIP) and VIP receptors-elucidation of structure and function for therapeutic applications","volume":"2","author":"Igarashi","year":"2011","journal-title":"Int. J. Physical Med. Rehabilit."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0415","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.peptides.2010.10.021","article-title":"Novel vasoactive intestinal peptide derivatives with improved stability protect rat alveolar L2 cells from cigarette smoke-induced cytotoxicity and apoptosis","volume":"32","author":"Misaka","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0420","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.200909-1451OC","article-title":"Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis","volume":"182","author":"Prasse","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0425","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.regpep.2010.05.017","article-title":"Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs","volume":"164","author":"Samarasinghe","year":"2010","journal-title":"Regul. Pept."},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0430","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2249.2009.03956.x","article-title":"Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease","volume":"157","author":"Smalley","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2021.11.040_bb0435","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1039\/b927192a","article-title":"Hydrothermal synthesis of novel alpha alumina nano-materials with controlled morphologies and high thermal stabilities","volume":"12","author":"Suchanek","year":"2010","journal-title":"CrystEngComm"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0440","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.powtec.2014.02.059","article-title":"Preparation of nano \u03b1-alumina powder and wear resistance of nanoparticles reinforced composite coating","volume":"257","author":"Chen","year":"2014","journal-title":"Powder Technol."},{"issue":"3","key":"10.1016\/j.jconrel.2021.11.040_bb0445","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.micromeso.2011.03.033","article-title":"Synthesis of ordered mesoporous alumina with large pore sizes and hierarchical structure","volume":"143","author":"Wu","year":"2011","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0450","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.matlet.2012.02.056","article-title":"A novel method to synthesis mesoporous alumina with visible emission by thermolysis of Al-based coordination polymer","volume":"76","author":"He","year":"2012","journal-title":"Mater. Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0455","first-page":"28","article-title":"Synthesis of nanofiber-like mesoporous gamma-Al2O3 toward its adsorption efficiency for Congo red","volume":"96","author":"Ghosh","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0460","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jallcom.2012.01.145","article-title":"Development of nano-alumina based ceramic components for high heat flux insulation applications under dynamic load","volume":"524","author":"Mishra","year":"2012","journal-title":"J. Alloys Compd."},{"issue":"33","key":"10.1016\/j.jconrel.2021.11.040_bb0465","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.micromeso.2010.09.033","article-title":"Facile synthesis of ordered mesoporous \u03b1-alumina monoliths via polymerization-based gel-casting","volume":"138","author":"Yuan","year":"2011","journal-title":"Microporous Mesoporous Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0470","first-page":"563","article-title":"Characterization and antibacterial activity of nickel ferrite doped \u03b1-alumina nanoparticle","volume":"20","author":"Ishaq","year":"2017","journal-title":"Eng. Sci. Technol Int. J."},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0475","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00253-012-4118-9","article-title":"Metallic oxide nanoparticles: state of the art in biogenic syntheses and their mechanisms","volume":"95","author":"Duran","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.jconrel.2021.11.040_bb0480","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1748-0132(07)70084-1","article-title":"Magnetic nanoparticles for drug delivery","volume":"2","author":"Arruebo","year":"2007","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0485","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2019.05.003","article-title":"Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases","volume":"47","author":"Kandikattu","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0490","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cyto.2015.09.013","article-title":"Oxyresveratrol ameliorates allergic airway inflammation via attenuation of IL-4, IL-5, and IL-13 expression levels","volume":"76","author":"Ashraf","year":"2015","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.jconrel.2021.11.040_bb0495","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.phymed.2016.04.006","article-title":"Pistacia integerrima ameliorates airway inflammation by attenuation of TNF-alpha, IL-4, and IL-5 expression levels, and pulmonary edema by elevation of AQP1 and AQP5 expression levels in mouse model of ovalbumin-induced allergic asthma","volume":"23","author":"Rana","year":"2016","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.jconrel.2021.11.040_bb0500","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1011037807261","article-title":"Water-soluble and low molecular weight chitosan-based plasmid DNA delivery","volume":"18","author":"Lee","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0939-6411(03)00155-3","article-title":"Chitosan\u2013DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy","volume":"57","author":"Mansouri","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0510","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/B978-0-12-818433-2.00015-7","article-title":"Chitosan for gene, DNA vaccines, and drug delivery","author":"dos Santos Rodrigues","year":"2019","journal-title":"Mater. Biomed. Eng."},{"issue":"1-2","key":"10.1016\/j.jconrel.2021.11.040_bb0515","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijpharm.2017.11.045","article-title":"Lipid coated chitosan-DNA nanoparticles for enhanced gene delivery","volume":"535","author":"Baghdan","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0520","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2009.08.004","article-title":"Chitosan-based formulations for delivery of DNA and siRNA","volume":"62","author":"Mao","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0525","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.colsurfa.2013.12.022","article-title":"Chitosan\u2013DNA complexes: effect of molecular parameters on the efficiency of delivery","volume":"460","author":"Bordi","year":"2014","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"issue":"1-2","key":"10.1016\/j.jconrel.2021.11.040_bb0530","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2009.03.032","article-title":"Low molecular weight chitosan in DNA vaccine delivery via mucosa","volume":"375","author":"Yang","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105159","article-title":"Lipid-based nanocarriers for delivery of small interfering RNA for therapeutic use","volume":"142","author":"Parashar","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118798","article-title":"Effect of hydrophobic tails of plier-like cationic lipids on nucleic acid delivery and intracellular trafficking","volume":"573","author":"Pengnam","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0545","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1359-0294(00)00090-X","article-title":"Liposome application: problems and prospects","volume":"6","author":"Barenholz","year":"2001","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0550","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/(SICI)1521-3773(19980803)37:13\/14<1768::AID-ANIE1768>3.0.CO;2-4","article-title":"Cationic liposomes for gene therapy","volume":"37","author":"Miller","year":"2004","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0555","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2109.2012.03209.x","article-title":"Highly efficient double-stranded RNA transfection of penaeid shrimp using cationic liposomes","volume":"45","author":"Apiratikul","year":"2013","journal-title":"Aquac. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2021.11.040_bb0560","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/cbin.11297","article-title":"Involvement of intracellular caveolin-1 distribution in the suppression of antigen-induced mast cell activation by cationic liposomes","volume":"44","author":"Inoh","year":"2020","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0565","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.omtn.2019.12.033","article-title":"Nanoparticle delivery of anti-inflammatory LNA oligonucleotides prevents airway inflammation in a HDM model of asthma","volume":"19","author":"Ramelli","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0570","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2021.11.040_bb0575","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/acs.nanolett.8b01101","article-title":"Lipid nanoparticle formulations for enhanced co-delivery of siRNA and mRNA","volume":"18","author":"Ball","year":"2018","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0580","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1021\/jm010918g","article-title":"Synthesis of novel cationic lipids:effect of structural modification on the efficiency of gene transfer","volume":"45","author":"Heyes","year":"2002","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.jconrel.2021.11.040_bb0585","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1620\/tjem.199.193","article-title":"Transient relief of asthma symptoms during jaundice: a possible beneficial role of bilirubin","volume":"199","author":"Ohrui","year":"2003","journal-title":"Tohoku J. Exp. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2021.11.040_bb0590","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.4049\/jimmunol.174.6.3709","article-title":"Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration","volume":"174","author":"Keshavan","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0595","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biomaterials.2017.06.014","article-title":"Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma","volume":"140","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0600","first-page":"46","article-title":"Anti-allergic rhinitis effects of caffeoylquinic acids from the fruits of Xanthium strumarium in rodent animals via alleviating allergic and inflammatory reactions","volume":"29","author":"Peng","year":"2019","journal-title":"Rev. Bras"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0605","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/molecules24020359","article-title":"Traditional uses, botany, phytochemistry, pharmacology, pharmacokinetics and toxicology of Xanthium strumarium L.: a review","volume":"24","author":"Fan","year":"2019","journal-title":"Molecules"},{"issue":"35","key":"10.1016\/j.jconrel.2021.11.040_bb0610","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1016\/j.vaccine.2018.07.040","article-title":"Polysaccharides as vaccine adjuvants","volume":"36","author":"Sun","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.08.054","article-title":"Immunomodulatory properties of chitosan polymers","volume":"184","author":"Moran","year":"2018","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0620","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jbm.a.30798","article-title":"Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation","volume":"79A","author":"Yoshida","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"sup1","key":"10.1016\/j.jconrel.2021.11.040_bb0625","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/17435390.2013.816798","article-title":"Immunotoxicity and genotoxicity testing of PLGA-PEO nanoparticles in human blood cell model","volume":"9","author":"Tulinska","year":"2015","journal-title":"Nanotoxicology"},{"issue":"3","key":"10.1016\/j.jconrel.2021.11.040_bb0630","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13346-020-00724-5","article-title":"Cyclodextrins in drug delivery: applications in gene and combination therapy","volume":"10","author":"Haley","year":"2020","journal-title":"Drug Deliv. Translat. Res."},{"issue":"9","key":"10.1016\/j.jconrel.2021.11.040_bb0635","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s11095-017-2187-2","article-title":"Impact of the charge ratio on the in vivo immunogenicity of lipoplexes","volume":"34","author":"Heidari","year":"2017","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2021.11.040_bb0640","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/cnma.201800648","article-title":"Gold nanorattles with intense raman in silica nanoparticles (nano-IRIS) as multimodal system for imaging and therapy","volume":"5","author":"Ahlawat","year":"2019","journal-title":"ChemNanoMat"},{"issue":"25","key":"10.1016\/j.jconrel.2021.11.040_bb0645","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1002\/adma.201400238","article-title":"Nano-gold as artificial enzymes: hidden talents","volume":"26","author":"Lin","year":"2014","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0650","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nantod.2018.06.006","article-title":"Ultrasmall noble metal nanoparticles: breakthroughs and biomedical implications","volume":"21","author":"Jiang","year":"2018","journal-title":"Nano Today"},{"issue":"7","key":"10.1016\/j.jconrel.2021.11.040_bb0655","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.nano.2013.04.009","article-title":"Osseointegration of titanium with an antimicrobial nanostructured noble metal coating","volume":"9","author":"Svensson","year":"2013","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.jconrel.2021.11.040_bb0660","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/inf2.12092","article-title":"Strain modulation of phase transformation of noble metal nanomaterials","volume":"2","author":"Wu","year":"2020","journal-title":"InfoMat"},{"issue":"6","key":"10.1016\/j.jconrel.2021.11.040_bb0665","doi-asserted-by":"crossref","first-page":"1801407","DOI":"10.1002\/admi.201801407","article-title":"Protein-induced shape control of noble metal nanoparticles","volume":"6","author":"Chakraborty","year":"2019","journal-title":"Adv. Mater. Interfaces"},{"issue":"6","key":"10.1016\/j.jconrel.2021.11.040_bb0670","doi-asserted-by":"crossref","first-page":"1800854","DOI":"10.1002\/adhm.201800854","article-title":"Gold nanoparticles with antibiotic-metallopolymers toward broad-spectrum antibacterial effects","volume":"8","author":"Yang","year":"2019","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0675","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1021\/ja078176p","article-title":"Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging","volume":"130","author":"Alric","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0680","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/NSA.S3788","article-title":"Applications of gold nanoparticles in cancer nanotechnology","volume":"1","author":"Cai","year":"2008","journal-title":"Nanotechnol. Sci. Appl."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0685","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.addr.2008.03.016","article-title":"Gold nanoparticles in delivery applications","volume":"60","author":"Ghosh","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"19","key":"10.1016\/j.jconrel.2021.11.040_bb0690","doi-asserted-by":"crossref","first-page":"1800510","DOI":"10.1002\/adhm.201800510","article-title":"Peptide\u2013gold nanoparticle hybrids as promising anti-inflammatory nanotherapeutics for acute lung injury: in vivo efficacy, biodistribution, and clearance","volume":"7","author":"Xiong","year":"2018","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0695","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jphotobiol.2018.12.015","article-title":"Biosynthesis of gold nanoparticles using Caffeoylxanthiazonoside, chemical isolated from Xanthium strumarium L. fruit and their Anti-allergic rhinitis effect- a traditional Chinese medicine","volume":"192","author":"Peng","year":"2019","journal-title":"J. Photochem. Photobiol. B"},{"issue":"10","key":"10.1016\/j.jconrel.2021.11.040_bb0700","doi-asserted-by":"crossref","first-page":"1603070","DOI":"10.1002\/smll.201603070","article-title":"Local effects on airway inflammation and systemic uptake of 5 nm PEGylated and citrated gold nanoparticles in asthmatic mice","volume":"13","author":"Omlor","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0705","doi-asserted-by":"crossref","first-page":"14832","DOI":"10.1021\/ja0364120","article-title":"Dendrimer-encapsulated nanoparticle precursors to supported platinum catalysts","volume":"125","author":"Lang","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0710","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1002\/anie.200453703","article-title":"Ruthenium nanoparticles supported on hydroxyapatite as an efficient and recyclable catalyst for cisdihydroxylation and oxidative cleavage of alkenes","volume":"43","author":"Ho","year":"2004","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0715","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/ar020204f","article-title":"Small is different: shape-, size-, and composition dependent properties of some colloidal semiconductor nanocrystals","volume":"37","author":"MA","year":"2004","journal-title":"Acc. Chem. Res."},{"issue":"15","key":"10.1016\/j.jconrel.2021.11.040_bb0720","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1016\/j.poly.2007.05.056","article-title":"Facile synthesis of silver nano particles with highly efficient anti-microbial property","volume":"26","author":"Sarkar","year":"2007","journal-title":"Polyhedron"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0725","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.matlet.2014.03.134","article-title":"One step green synthesis and anti-microbial and anti-biofilm properties of Psidium guajava L. leaf extract-mediated silver nanoparticles","volume":"125","author":"Gupta","year":"2014","journal-title":"Mater. Lett."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0730","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.molliq.2017.08.037","article-title":"Synthesis and bio-physical characterization of Silver nanoparticle and Ag-mesoporous MnO2 nanocomposite for anti-microbial and anti-cancer activity","volume":"243","author":"Ramalingam","year":"2017","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0735","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.matchemphys.2019.02.064","article-title":"Green synthesis and characterization of silver nanoparticles using belladonna mother tincture and its efficacy as a potential antibacterial and anti-inflammatory agent","volume":"228","author":"Das","year":"2019","journal-title":"Mater. Chem. Phys."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2019.111558","article-title":"Garlic clove extract assisted silver nanoparticle - Antibacterial, antibiofilm, antihelminthic, anti-inflammatory, anticancer and ecotoxicity assessment","volume":"198","author":"Vijayakumar","year":"2019","journal-title":"J. Photochem. Photobiol. B"},{"issue":"4","key":"10.1016\/j.jconrel.2021.11.040_bb0745","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3342\/ceo.2012.5.4.222","article-title":"The effect of nano-silver on allergic rhinitis model in mice","volume":"5","author":"Shin","year":"2012","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0750","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2147\/IJN.S11664","article-title":"Attenuation of allergic airway inflammation and hyperresponsiveness in a murine model of asthma by silver nanoparticles","volume":"5","author":"Park","year":"2010","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0755","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1006\/pupt.2001.0319","article-title":"Reactive oxygen species as mediators in asthma","volume":"14","author":"Henricks","year":"2001","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0760","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1038\/sj.onc.1203237","article-title":"The Rel\/NF-kappaB signal transduction pathway: introduction","volume":"18","author":"TD","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0765","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0165-6147(97)89796-9","article-title":"NF-kappa B: a pivotal role in asthma and a new target for therapy","volume":"18","author":"Barnes","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0770","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/smll.201301597","article-title":"Use of coated silver nanoparticles to understand the relationship of particle dissolution and bioavailability to cell and lung toxicological potential","volume":"10","author":"Wang","year":"2014","journal-title":"Small"},{"issue":"9","key":"10.1016\/j.jconrel.2021.11.040_bb0775","doi-asserted-by":"crossref","first-page":"1602363","DOI":"10.1002\/smll.201602363","article-title":"5 nm silver nanoparticles amplify clinical features of atopic dermatitis in mice by activating mast cells","volume":"13","author":"Kang","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0780","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jconrel.2013.02.002","article-title":"Suppression of immune response by antigen-modified liposomes encapsulating model agents: a novel strategy for the treatment of allergy","volume":"167","author":"Ichikawa","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105172","article-title":"Preventive effects of \u201covalbumin-conjugated celastrol-loaded nanomicelles\u201d in a mouse model of ovalbumin-induced allergic airway inflammation","volume":"143","author":"Peng","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0790","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0795","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"Smith","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0800","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nano.2018.11.010","article-title":"A dual fluorescent reverse targeting drug delivery system based on curcumin-loaded ovalbumin nanoparticles for allergy treatment","volume":"16","author":"Liang","year":"2019","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/j.jconrel.2021.11.040_bb0805","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10753-020-01181-5","article-title":"A20-OVA nanoparticles inhibit allergic asthma in a murine model","volume":"43","author":"Luo","year":"2020","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.jconrel.2021.11.040_bb0810","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/mabi.200500233","article-title":"Determination of chitin and protein contents during the isolation of chitin from shrimp waste","volume":"6","author":"Diaz-Rojas","year":"2006","journal-title":"Macromol. Biosci."},{"issue":"30","key":"10.1016\/j.jconrel.2021.11.040_bb0815","doi-asserted-by":"crossref","first-page":"47804","DOI":"10.1002\/app.47804","article-title":"Valorization of chitins extracted from North Morocco shrimps: comparison of chitin reactivity and characteristics","volume":"136","author":"Arrouze","year":"2019","journal-title":"J. Appl. Polym. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2021.11.040_bb0820","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/jctb.1437","article-title":"Production of high-quality chitin and chitosan from preconditioned shrimp shells","volume":"81","author":"Toan","year":"2006","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0825","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4049\/jimmunol.164.3.1314","article-title":"Oral administration of chitin down-regulates serum IgE levels and lung eosinophilia in the allergic mouse","volume":"164","author":"Shibata","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0830","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0264-410X(00)00248-6","article-title":"Immune stimulating activity of two new chitosan containing adjuvant formulations","volume":"19","author":"Seferian","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0835","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1046\/j.1365-2222.2002.01551.x","article-title":"Intranasal application of chitin microparticles down-regulates symptoms ofallergic hypersensitivity to Dermatophagoides pteronyssinus and Aspergillusfumigatus in murine models of allergy","volume":"32","author":"Strong","year":"2002","journal-title":"Clin. Exp. Allergy"},{"issue":"7","key":"10.1016\/j.jconrel.2021.11.040_bb0840","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1365-2222.2006.02515.x","article-title":"Treatment with chitin microparticles is protective against lung histopathology in a murine asthma model","volume":"36","author":"Ozdemir","year":"2006","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0845","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0850","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/BOR.0b013e32835cb9f2","article-title":"Dendritic cell vaccination in autoimmune disease","volume":"25","author":"Gross","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0855","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2012-09-452078","article-title":"Targeting dendritic cells\u2014why bother?","volume":"121","author":"Kreutz","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0860","doi-asserted-by":"crossref","first-page":"17280","DOI":"10.1073\/pnas.1010263107","article-title":"Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells","volume":"107","author":"Stern","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0865","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.2337\/diabetes.54.12.3395","article-title":"On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes","volume":"54","author":"Bruder","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0870","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0875","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2002-10-3229","article-title":"Induction of CD4+\/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells","volume":"101","author":"Mahnke","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0880","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1089\/104303402760293547","article-title":"Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling","volume":"13","author":"Behera","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0885","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.4049\/jimmunol.166.10.6392","article-title":"IL-18 gene transfer by adenovirus prevents the development of and reverses established allergen-induced airway hyperreactivity","volume":"166","author":"Walter","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0890","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/emmm.201100142","article-title":"IL-28 A (IFN-\u03bb2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease","volume":"3","author":"Koltsida","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0895","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2016.06.043","article-title":"Mucosal expression of DEC-205 targeted allergen alleviates an asthmatic phenotype in mice","volume":"237","author":"Maaske","year":"2016","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2021.11.040_bb0900","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/all.13373","article-title":"Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: The one airway concept revisited","volume":"73","author":"Samitas","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105718","article-title":"Combined allergic rhinitis and asthma syndrome (CARAS)","volume":"74","author":"Paiva Ferreira","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.jconrel.2021.11.040_bb0910","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.clinthera.2017.10.006","article-title":"Management of allergic rhinitis: a review for the community pharmacist","volume":"39","author":"May","year":"2017","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0915","first-page":"155","article-title":"Inadequate diagnosis of nonallergic rhinitis: assessing the damage","volume":"24","author":"Ledford","year":"2003","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0920","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2500\/aap.2012.33.3603","article-title":"Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys","volume":"33","author":"Meltzer","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0925","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/all.12418","article-title":"Allergic rhinitis is a risk factor for traffic safety","volume":"69","author":"Vuurman","year":"2014","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.jconrel.2021.11.040_bb0930","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10965-019-1846-x","article-title":"PMAA nanogel controllably releases anti-IL-1\u03b2 IgY for treating allergic rhinitis","volume":"26","author":"Wu","year":"2019","journal-title":"J. Polym. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb0935","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbadis.2011.06.013","article-title":"The two faces of mast cells in food allergy and allergic asthma: the possible concept of Yin Yang","volume":"1822","author":"Kraneveld","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.jconrel.2021.11.040_bb0940","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jaip.2019.02.030","article-title":"IgE-mediated multimorbidities in allergic asthma and the potential for omalizumab therapy","volume":"7","author":"Humbert","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0945","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coi.2018.05.006","article-title":"Role of neutrophils in allergic asthma","volume":"54","author":"Radermecker","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"1-2","key":"10.1016\/j.jconrel.2021.11.040_bb0950","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pharmthera.2005.06.006","article-title":"Targeting memory Th2 cells for the treatment of allergic asthma","volume":"109","author":"Epstein","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0955","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1067\/mai.2003.104","article-title":"Efficacy of liposomal budesonide in experimental asthma","volume":"111","author":"Konduri","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb0960","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nano.2009.07.001","article-title":"Nanodelivery in airway diseases: challenges and therapeutic applications","volume":"6","author":"Roy","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0965","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/oxfordjournals.bmb.a071461","article-title":"Bronchial mucus in health and disease","volume":"34","author":"Lopez-Vidriero","year":"1978","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0970","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1164\/ajrccm.156.1.9606123","article-title":"Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients","volume":"156","author":"Deneuville","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0975","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-3-030-31745-4_12","article-title":"Nasal drug delivery","author":"Brunaugh","year":"2019","journal-title":"Essential Pharmaceutics"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0980","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2019.10.035","article-title":"Rational particle design to overcome pulmonary barriers for obstructive lung diseases therapy","volume":"314","author":"He","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0985","series-title":"Mucosal Immunology (Third Edition)","first-page":"49","article-title":"Chapter 4 - Mucus","author":"Cone","year":"2005"},{"key":"10.1016\/j.jconrel.2021.11.040_bb0990","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/17425247.5.6.629","article-title":"Biodegradable polymeric nanocarriers for pulmonary drug delivery","volume":"5","author":"Rytting","year":"2008","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"10.1016\/j.jconrel.2021.11.040_bb0995","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.addr.2008.09.011","article-title":"Extracellular barriers in respiratory gene therapy","volume":"61","author":"Sanders","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2 Suppl","key":"10.1016\/j.jconrel.2021.11.040_bb1000","article-title":"Mucosal gene expression vaccine: a novel vaccine strategy for respiratory syncytial virus","volume":"22","author":"Mohapatra","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1005","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.scitotenv.2016.09.056","article-title":"A critical review of approaches and limitations of inhalation bioavailability and bioaccessibility of metal(loid)s from ambient particulate matter or dust","volume":"574","author":"Kastury","year":"2017","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.envres.2018.11.014","article-title":"Particle deposition in the human lung: health implications of particulate matter from different sources","volume":"169","author":"Deng","year":"2019","journal-title":"Environ. Res."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2018.10.012","article-title":"Pulmonary surfactant and drug delivery: focusing on the role of surfactant proteins","volume":"291","author":"Guagliardo","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.040_bb1020","first-page":"47","author":"Kreyling","year":"2006","journal-title":"Particle dosimetry: deposition and clearance from the respiratory tract and translocation towards extra-pulmonary sites"},{"key":"10.1016\/j.jconrel.2021.11.040_bb1025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.12.040","article-title":"Influence of particle size on regional lung deposition \u2013 what evidence is there?","volume":"406","author":"Carvalho","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1030","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/jps.22003","article-title":"Swellable microparticles as carriers for sustained pulmonary drug delivery","volume":"99","author":"El-Sherbiny","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2021.11.040_bb1035","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0021-8502(86)90035-2","article-title":"Deposition of particles in the human respiratory tract in the size range 0.005-15 mm","volume":"17","author":"Heyder","year":"1986","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1513\/pats.200409-046TA","article-title":"Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery","volume":"1","author":"Heyder","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jconrel.2014.04.055","article-title":"Pulmonary drug delivery by powder aerosols","volume":"193","author":"Yang","year":"2014","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2021.11.040_bb1050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2016.04.012","article-title":"The formulation of nanomedicines for treating tuberculosis","volume":"102","author":"Costa","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-981-13-3642-3_9","article-title":"Inhalation drug therapy: emerging trends in nasal and pulmonary drug delivery","author":"Lalan","year":"2019","journal-title":"Novel Drug Deliv. Technol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1060","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jconrel.2017.11.036","article-title":"Inhalable particulate drug delivery systems for lung cancer therapy: nanoparticles, microparticles, nanocomposites and nanoaggregates","volume":"269","author":"Abdelaziz","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.040_bb1065","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.addr.2007.11.006","article-title":"Targeted delivery of nanoparticles for the treatment of lung diseases","volume":"60","author":"Azarmi","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1070","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/153303460400300615","article-title":"Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response","volume":"3","author":"Gopalan","year":"2004","journal-title":"Technol. Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.jconrel.2021.11.040_bb1075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0966-842X(02)02422-8","article-title":"The alveolar macrophage_ the Trojan horse of Bacillus anthracis","volume":"10","author":"Guidi-Rontani","year":"2002","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijpharm.2008.02.011","article-title":"Inhaled nanoparticles\u2014a current review","volume":"356","author":"Yang","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2014.10.022","article-title":"Chan H-K Inhaled formulations and pulmonary drug delivery systems for respiratory infections","volume":"85","author":"Zhou","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2021.11.040_bb1090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2010.12.017","article-title":"Comparative in vivo study of poly(ethylene imine)\/siRNA complexes for pulmonary delivery in mice","volume":"151","author":"Beyerle","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.040_bb1095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jgm.291","article-title":"Interaction of bronchoalveolar lavage fluid with polyplexes and lipoplexes: analysing the role of proteins and glycoproteins","volume":"5","author":"Rosenecker","year":"2003","journal-title":"J. Gene Med."},{"issue":"20","key":"10.1016\/j.jconrel.2021.11.040_bb1100","doi-asserted-by":"crossref","first-page":"1700478","DOI":"10.1002\/adhm.201700478","article-title":"Aspherical, nanostructured microparticles for targeted gene delivery to alveolar macrophages","volume":"6","author":"M\u00f6hwald","year":"2017","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.08.001","article-title":"Prostaglandins in asthma and allergic diseases","volume":"193","author":"Peebles","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb1110","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biomaterials.2012.08.070","article-title":"Airway delivery of peptides and proteins using nanoparticles","volume":"34","author":"Dombu","year":"2013","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jconrel.2021.11.040_bb1115","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jconrel.2011.12.004","article-title":"Controlled pulmonary drug and gene delivery using polymeric nano-carriers","volume":"161","author":"Beck-Broichsitter","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.040_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106690","article-title":"DC-targeted gold nanoparticles as an efficient and biocompatible carrier for modulating allergic responses in sublingual immunotherapy","volume":"86","author":"Sadeghi","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.jconrel.2021.11.040_bb1125","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/s13346-020-00816-2","article-title":"Nose-to-brain drug delivery mediated by polymeric nanoparticles: influence of PEG surface coating","volume":"10","author":"de Oliveira Junior","year":"2020","journal-title":"Drug Deliv. Translat. Res."},{"key":"10.1016\/j.jconrel.2021.11.040_bb1130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","article-title":"Mucoadhesive vs. mucopenetrating particulate drug delivery","volume":"98","author":"Netsomboon","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.jconrel.2021.11.040_bb1135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/cmmi.1678","article-title":"Specific targeting and noninvasive magnetic resonance imaging of an asthma biomarker in the lung using polyethylene glycol functionalized magnetic nanocarriers","volume":"11","author":"Al Faraj","year":"2016","journal-title":"Contrast Media Mol. Imag."},{"issue":"12","key":"10.1016\/j.jconrel.2021.11.040_bb1140","doi-asserted-by":"crossref","first-page":"11642","DOI":"10.1021\/acsnano.5b04026","article-title":"Tracking of inhaled near-infrared fluorescent nanoparticles in lungs of SKH-1 mice with allergic airway inflammation","volume":"9","author":"Andrea Markus","year":"2015","journal-title":"ACS Nano"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921006350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921006350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:16:17Z","timestamp":1759162577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921006350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":228,"alternative-id":["S0168365921006350"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.040","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging micro\/nano-platform and airway allergy intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}